Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro

Gene Therapy

Volumn 7, Issue 5, 2000, Pages 408-416

  Klebba, C ^a   Ottmann, O G ^a   Scherr, M ^b   Pape, M ^a   Engels, J W ^a   Grez, M ^c   Hoelzer, D ^a   Klein, S A ^a,d  

^a GOETHE UNIVERSITY   (Germany)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AIDS; Gene therapy; Hairpin ribozyme; Lymphocytes; Retroviral vector

Indexed keywords

CD4 ANTIGEN; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; RIBOZYME; VIRUS VECTOR;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034103587     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301094     Document Type: Article

References (24)

1. Sarver N et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 1990; 247: 1222-1225.
2. Ojwang JO et al. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc Natl Acad Sci USA 1992; 89: 10802-10806.
3. Rossi JJ, Sarver N, RNA enzymes (ribozymes) as antiviral therapeutic agents. Trends Biotechnol 1990; 8: 179-183.
4. Gervaix A et al. Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals. Hum Gene Ther 1997; 8: 2229-2238.
5. + cells from HIV-exposed infants: preclinical studies. Gene Therapy 1998; 5: 233-239.
6. Rossi JJ, Ribozymes. Curr Opin Biotechnol 1992; 3: 3-7.
7. Yu M et al. In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1. Virology 1995; 206: 381-386.
8. Wang L et al. Preclinical characterization of an anti-tat ribozyme for therapeutic application. Hum Gene Ther 1998; 9: 1283-1291.
9. Zhou C et al. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 1994; 149: 33-39.
10. Yamada O et al. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Therapy 1994; 1: 38-45.
11. Wong-Staal F, Poeschla EM, Looney DJ. A controlled, phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum Gene Ther 1998; 9: 2407-2425.
12. Perelson AS et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 1582-1586.
13. + T lymphocytes. Gene Therapy 1996; 3: 695-705.
14. Yamada O et al. Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells. Virology 1994; 205: 121-126.
15. Ramezani A, Ding SF, Joshi S. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes. Gene Therapy 1997; 4: 861-867.
16. Larsson S et al. A novel ribozyme target site located in the HIV-1 nef open reading frame. Virology 1996; 219: 161-169.
17. Lo KM et al. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virology 1992; 190: 176-183.
18. Zhou C, Bahner I, Rossi JJ, Kohn DB. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition. Antisense Nucleic Acid Drug Dev 1996; 6: 17-24.
19. Ramezani A, Joshi S. Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo. Antisence Nucleic Acid Drug Dev 1996; 6: 229-235.
20. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.
21. Onodera M et al. Development of improved adenosine deaminase retroviral vectors. J Virol 1998; 72: 1769-1774.
22. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
23. Hart H et al. A comparison of polymerase chain reaction and an infectivity assay for human immunodeficiency virus type 1 titration during virus inactivation of blood components. Transfusion 1993; 33: 838-841.
24. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Meth 1994; 170: 145-157.